tions available for such patients. However, hemodynamic stabilization is often necessary for such patients until a specific intervention can be performed. The intra-aortic balloon pump has commonly been used for this purpose.' Though effective, the intraaortic balloon pump is expensive and can only rarely be implemented rapidly, since it requires a trained physician or surgeon for insertion. In addition, it cannot be used in patients with severe peripheral vascular disease. By virtue of its invasive nature, the intra-aortic balloon pump may cause vascular complications that are, in themselves, life threatening. 2 For many years, efforts have been targeted at developing a noninvasive technique of assisted circulation that would have wider application and be of use in a community hospital setting. Several investi- ters that had been previously defined as being optimal for augmenting aortic flow and pressure. 16 Methods Two protocols were implemented after approval from the Johns Hopkins Medical Institutions Animal Care and Use Committee. These protocols conformed to the guiding principles of the American Physiological Society. In protocol 1, changes in coronary flow and hemodynamics during prolonged cardiac depression were assessed (control group). In protocol 2, the effect of assisted circulation by manipulation of intrathoracic pressure on vital organ perfusion was studied (intervention group).
General Animal Preparation
Thirteen mongrel dogs (20-25 kg) were anesthetized with phenobarbital (4 mg/kg i.v.) and intubated. All dogs were ventilated with a Harvard ventilator (model 607, Harvard Apparatus, South Natick, Mass.) with a tidal volume of 10 ml/kg at a rate of 10-15 breaths/min. Supplemental phenobarbital was administered as needed to maintain anesthesia. A left-sided thoracotomy was performed, and the ascending aorta, just above the coronary ostia, was exposed. For dogs in protocol 2, an aortic flow probe (model 501A, Carolina Medical Electronics, King, N.C.) was positioned and secured around the exposed ascending aorta. The flow probe had been calibrated with blood before and after the initiation of these studies. In all dogs, a small pericardial incision was made, and bipolar atrial and ventricular electrodes were sewn to the left atrial appendage and LV apex, respectively. The chest was closed in layers and evacuated of air, and the flow probe wires and electrodes were tunneled under the skin and brought out near the lower rib cage. Micromanometer-tipped catheters (Millar, Houston) were inserted in the femoral arteries and veins and advanced to the LV, thoracic aorta, and right atrium. Changes in right atrial pressure were used to estimate changes in intrathoracic pressure.16 In addition, both axillary arteries were exposed and cannulated with thin, polyethylene catheters that were advanced and positioned in the brachiocephalic arteries. These catheters were subsequently used for arterial blood sampling.
Data were recorded on an eight-channel recorder (model 2800S, Gould, Inc., Cleveland, Ohio) and were also digitized at a rate of 100 Hz and stored by computer on a disk. After recording baseline aortic flow and aortic, LV, and right atrial pressures, cardiac contractility was depressed with high doses of intravenous propranolol (23+12 mg) and verapamil (23+13 mg), and the heart was sequentially paced atrioventricularly after bradycardia (<60 beats/min) developed. The heart was paced at a rate of 72 beats/min with an atrioventricular pacing interval of 100 msec using an R wave coupled-pulse generator (model 5837, Medtronic Inc., Minneapolis, Minn.). In all dogs verapamil and propranolol were administered until aortic flow decreased by 40% or greater and peak LV pressure was reduced below 100 mm Hg. Two to 3 minutes was allowed to confirm the hemodynamic effects of propranolol and verapamil, and the protocol was then initiated.
Microsphere-Determined Blood Flow Measurements
Baseline blood flow and blood flow following cardiac depression and during assisted circulation were determined by injecting 15±3-,im-diameter radiolabeled microspheres (141Ce, "13Sn, 103Ru, 95Nb, 153Gd, 465c, New England Nuclear, Boston) into the LV.
Regional blood flows were determined according to techniques previously described.18"19 Reference samples were withdrawn from the two axillary artery catheters with a dual syringe pump (model 600, Harvard Apparatus). Withdrawal was started 15 seconds before injection and continued for 3 minutes at a rate of 3.8 ml/min for samples drawn before the induction of cardiac depression and 1.9 ml/min for 6 minutes for all samples drawn after cardiac depression had been induced and also during assisted circulation. The validity of using microspheres for low-flow states has been previously documented.18 '20 Circulatory Assistance System
The system used to generate intrathoracic pressure variations has been described in detail elsewhere. 13 In brief, this system consisted of an inflatable vest connected to a pneumatic system controlled by solenoid valves and fed by an external source of compressed air. A dedicated computer controlled the timing and duration of intrathoracic pressure waves relative to the atrial signal from the atrioventricular sequential pacemaker. The amplitude of the intrathoracic pressure wave was set by controlling the vest inflation pressure. Vest inflation pressure was titrated to get the desired change in intrathoracic pressure. The intrathoracic pressure wave parameters used in this study had been previously defined as being optimal for augmenting aortic flow and pressure.'6 During this study, the rise in intrathoracic pressure was synchronous with LV isovolumic contraction, lasted 400 msec, and was [20] [21] [22] [23] [24] [25] Protocol 2: Assessment of regional flow during assisted circulation. The purpose of this study was to compare regional flows during cardiac depression to flows during assisted circulation by manipulation of intrathoracic pressure. Seven dogs were studied and served as the intervention group. The timing of microsphere injections was the same as noted above. However, in this protocol, on completion of blood sample withdrawal after microsphere injection at 1 minute of cardiac depression, assisted circulation was initiated at 7 minutes and continued for an additional 6 minutes. The second microsphere injection was made during assisted circulation. The final microsphere injection was made at 14 minutes, on termination of assisted circulation. Tissues were harvested, and tissue and blood sample counts and flow were determined as previously described. [17] [18] [19] Hemodynamic data were analyzed by a program that averaged 5-second samples and calculated the average aortic flow and the average peak systolic and diastolic pressure (relative to atmosphere) for each measurement location during the data-sampling period. Computer pressure readings were compared with visual pressure readings from the strip-chart recording to confirm the accuracy of the measurement. Estimated systolic LV transmural pressure (defined as peak LV systolic pressure minus peak change in right atrial pressure, assuming that right atrial pressure reflected the change in intrathoracic pressure) was also calculated.2'
Statistical Analysis
Values of pressures and flows were obtained from 5-second averages. Differences in paired data and group data were tested using a two-tailed paired t test or an analysis of covariance, as appropriate. Data are expressed as mean+SEM.
Results
Hemodynamics and Coronary Flow During Prolonged Cardiac Depression: Control Group Table 1 and Figure 1 depict the changes in hemodynamics and coronary flow for a 14-minute period after the induction of pharmacological cardiac depression. These experiments also established the characteristics of the animal model used. At 1 minute after the onset of cardiac depression, a significant decrease in aortic and LV systolic pressures and a significant increase in LV diastolic and right atrial pressure were observed. At 7 and 14 minutes of cardiac depression, a gradual decrease in both aortic and LV systolic and aortic diastolic pressures was noted but did not achieve statistical significance. Coronary flow fell from 129.1+14.4 to 51.6+11.3 ml/100 g/min (p<0.005) after the induction of cardiac depression at 1 minute and continued to decrease for the first 7 minutes (p<0.005), likely reflecting ongoing drug effect. At 14 minutes, coronary flow was still lower (20.7+9.5 ml/100 g/min). The ongoing fall in coronary flow during sustained cardiac depression was likely due to changes in coronary vascular resistance as a consequence of increased Figure 1 , coronary flow was comparable with the flow in the control dogs before the induction of cardiac depression and at 1 minute after the induction of cardiac depression. During assisted circulation at 7 minutes, significantly greater coronary flow was noted in the intervention group than in the control group (55.8±19.2 versus 32.2±+11.5 ml/100 g/min,p<0.05). After termination of assisted circulation, coronary flow fell, and there was no difference in coronary flow between the two groups of dogs at 14 minutes (p=NS). During assisted circulation, a significant increase in blood flow to the brain, kidney, and small intestine was also noted ( Table 2) . No significant change in hepatic flow was observed. On termination of assisted circulation, all organ flows fell significantly. Figure 2 depicts the changes in hemodynamics during assisted circulation in a representative dog. Table 2 lists hemodynamic and regional flow data for four time periods: before the induction of cardiac depression (control), 1 minute after the onset of cardiac depression (before intervention, 1-minute depression), during assisted circulation (intervention, 7-minute depression), and after the termination of the intervention (after intervention, 14-minute depression). The increase in aortic and coronary flow during assisted circulation (at 7 minutes) was accompanied by a simultaneous increase in aortic and LV pressures and a significant decrease in estimated LV transmural pressure.
Discussion
The mechanism for blood flow during cardiac arrest in humans remains unclear but is likely due to both manipulation of intrathoracic pressure and cardiac/vascular compression. Manipulation of intrathoracic pressure has, however, been shown to be a potent mechanism for generating blood flow during FIGURE 1. Bar graph showing microspheredetermined blood flow during cardiac depression for 14 minutes. Coronary blood flow was measured in six dogs (control group) before (PRE DEP) and at 1, 7, and 14 minutes after induction of cardiac depression. Coronary and brain bloodflows were measured in seven dogs (intervention group) before and at 1, 7, and 14 minutes after induction of cardiac depression. However, in the intervention group, assisted circulation (by manipulation of intrathoracic pressure) was initiated at 7 minutes and continued for an additional 6 minutes; the final measurement was determined after termination ofassisted circulation (at 14 minutes). During assisted circulation at 7 minutes, there is a significant increase in coronaryflow in the intervention group vs. the control group. During assisted circulation, brain blood flow also increases. sure in the nonarrested but severely depressed circulation.13 Using this pneumatic vest system, Beyar et a116 showed that significant aortic flow and pressure augmentation occurred when the rise in intrathoracic pressure was synchronous with, preceded, or followed LV isovolumic contraction by 40 msec. This increase in aortic flow was associated with an increase in aortic pressure and a simultaneous decrease in estimated LV transmural pressure as confirmed by these experiments. These data also suggested that relatively low-pressure intrathoracic waves synchronous with LV contraction could provide an effective noninvasive circulatory-assist method for the failing heart in the dog and likely had potential for human use. However, the clinical applicability of any technique of assisted circulation would depend largely on its effect on vital organ perfusion. Our present studies confirm that assisted circulation by manipulation of intrathoracic pressure also increases vital organ flow. The magnitude of increase in coronary flow is similar if not greater than that reported with the intra-aortic balloon pump. 24 These data are encouraging, since the relatively low range of intrathoracic pressures used during assisted circulation (25- Another limitation of this study is that blood gases were not monitored during the protocol. Since the mechanism of intrathoracic pressure rise is transient airway collapse, hypoxemia may have occurred during assisted circulation. This was not formally evaluated. However, there was no clinical evidence of hypoxemia, though the possibility of a modest degree of hypoxemia cannot be ruled out. The other limitation of this study is that, as demonstrated by the control dogs, the animal model of "cardiac depression" used is inherently unstable and represents an "acute" model of heart failure. Though vascular pressures declined over 20 minutes, the similarity of hemodynamics at 1 minute and 14 minutes after depression in the control and assisted-circulation dogs allows us to study the hemodynamic effects of assisted circulation before, during, and after circulatory support. Since hemodynamics at 14 minutes are comparable in the two groups of dogs (control and intervention), the fall in aortic pressure in the intervention group after circulatory support cannot be a consequence of the intervention. This technique of assisted circulation has only been studied in an acute model of heart failure; based on the mechanism of benefit, it is likely to be effective in situations of chronic severe heart failure as well.
Thus, it appears that modest increments (25-30 mm Hg) in intrathoracic pressure occurring synchronously with isovolumic LV contraction and lasting for 35-50% of the cardiac cycle can effectively increase peripheral and vital organ flow and pressure without increasing estimated LV transmural pressure. The technique used to manipulate intrathoracic pressure is unique in that it is noninvasive and is effective at low vest pressures. With this noninvasive technique of assisted circulation, significant flow and pressure augmentation can be realized. Though these initial results are encouraging, they must be viewed with caution, since the duration of intervention studied was short and the magnitude of flow increase was modest. Significantly longer durations of support should be studied, and the effectiveness of this technique in terms of sustained hemodynamic benefit and safety after such prolonged support should be established. If found to be effective, this technique could potentially be used during patient transportation or immediately after cardiopulmonary resuscitation. By virtue of its noninvasive character, this technique of assisted circulation may lend itself to a wide spectrum of clinical uses.
